Published in Ann Oncol on December 13, 2013
Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014). Ann Oncol (2014) 1.08
Hospital admission of cancer patients: avoidable practice or necessary care? PLoS One (2015) 0.87
A Qualitative Study of Medical Oncologists' Experiences of Their Profession and Workforce Sustainability. PLoS One (2016) 0.75
ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016. Ann Oncol (2016) 0.75
Reply to the letter to the editor 'Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper' by Valentini et al. Ann Oncol (2014) 0.75
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open (2016) 0.75
The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe. ESMO Open (2016) 0.75
Status of oncologic specialties: global survey of physicians treating cancer. Int J Clin Oncol (2016) 0.75
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med (2013) 13.90
Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol (1995) 9.03
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J (1995) 6.94
Inactivation of Ca channels. Prog Biophys Mol Biol (1984) 6.09
MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol (1999) 5.75
Calcium entry leads to inactivation of calcium channel in Paramecium. Science (1978) 5.75
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab. Ann Oncol (2007) 5.68
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32
Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods. J Antimicrob Chemother (1978) 5.23
High-resolution crystal structure of cytochrome P450cam. J Mol Biol (1987) 4.63
Salmonella enteritidis phage type 4 infection: association with hen's eggs. Lancet (1988) 4.31
Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab. Ann Oncol (2008) 4.27
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet (1998) 4.16
A voltage-sensitive persistent calcium conductance in neuronal somata of Helix. J Physiol (1976) 4.12
Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol (1995) 4.08
Calcium domains associated with individual channels can account for anomalous voltage relations of CA-dependent responses. Biophys J (1984) 3.91
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet (2005) 3.75
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J Clin Oncol (1997) 3.61
Dynamic force spectroscopy of single DNA molecules. Proc Natl Acad Sci U S A (1999) 3.50
Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis (2001) 3.36
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. J Clin Oncol (2001) 3.21
Calcium-mediated inactivation of the calcium conductance in caesium-loaded giant neurones of Aplysia californica. J Physiol (1981) 3.04
An enzymatic mechanism for calcium current inactivation in dialysed Helix neurones. J Physiol (1986) 2.99
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol (2002) 2.87
Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol (2005) 2.84
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol (2000) 2.77
Bioelectric control of ciliary activity. Science (1972) 2.72
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
Integrating a modern knowledge-based system architecture with a legacy VA database: the ATHENA and EON projects at Stanford. Proc AMIA Symp (1999) 2.68
Calcium couples flagellar reversal to photostimulation in Chlamydomonas reinhardtii. Nature (1976) 2.67
Ionic mechanisms of excitation in Paramecium. Annu Rev Biophys Bioeng (1979) 2.64
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. Ann Oncol (2010) 2.64
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol (2003) 2.63
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol (2002) 2.60
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer (2013) 2.58
Alpha B-crystallin is a small heat shock protein. Proc Natl Acad Sci U S A (1991) 2.56
Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study. J Natl Cancer Inst (2000) 2.56
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Ann Oncol (2010) 2.54
Gastric cancer: epidemiology, pathology and treatment. Ann Oncol (2003) 2.53
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure. Eur J Cancer (2009) 2.52
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. Ann Oncol (2014) 2.50
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours. Br J Cancer (2005) 2.49
Voltage-activated calcium channels that must be phosphorylated to respond to membrane depolarization. Proc Natl Acad Sci U S A (1987) 2.48
The long-term reproductive health consequences of female genital cutting in rural Gambia: a community-based survey. Trop Med Int Health (2001) 2.45
A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature (1997) 2.44
Simultaneous detection of bovine Theileria and Babesia species by reverse line blot hybridization. J Clin Microbiol (1999) 2.39
Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. Cancer (1995) 2.38
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol (2005) 2.33
A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res (2000) 2.32
Genetic modification of electric properties in an excitable membrane (paramecium-calcium conductance-electrophysiological measurements-membrane mutant). Proc Natl Acad Sci U S A (1972) 2.31
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 2.31
Contactpoint analysis of the HeLa nuclear factor I recognition site reveals symmetrical binding at one side of the DNA helix. EMBO J (1987) 2.30
Southern Ocean frontal structure and sea-ice formation rates revealed by elephant seals. Proc Natl Acad Sci U S A (2008) 2.24
Rectal metastases from lobular carcinoma of the breast: report of a case and literature review. Ann Oncol (2001) 2.23
Software for a diffractometer with multiwire area detector. Methods Enzymol (1985) 2.20
Questioning specialists' attitudes to breast cancer follow-up in primary care. Ann Oncol (2007) 2.19
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). Ann Oncol (2006) 2.19
The burden of reproductive-organ disease in rural women in The Gambia, West Africa. Lancet (2001) 2.16
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth. Ann Oncol (2002) 2.14
Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8. BMJ (1999) 2.14
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients. Ann Oncol (2007) 2.11
Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene (1999) 2.10
Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. Induction by cytokines and phorbol ester. J Immunol (1991) 2.09
Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr (2000) 2.07
Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial. Ann Oncol (2013) 2.06
A genome-wide survey of RAS transformation targets. Nat Genet (2000) 2.06
Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells. Ann Hematol (1996) 2.05
Management of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines. Ann Oncol (2012) 2.04
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie. Ann Oncol (2002) 2.03
Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008. Br J Dermatol (2012) 2.03
Crystal structure of substrate-free Pseudomonas putida cytochrome P-450. Biochemistry (1986) 2.00
Successful re-treatment with taxol after major hypersensitivity reactions. J Clin Oncol (1993) 2.00
Calcium-mediated inactivation of calcium current in Paramecium. J Physiol (1980) 1.97
Human feeder layers for human embryonic stem cells. Biol Reprod (2003) 1.94
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol (2009) 1.93
Patients' estimation of overall treatment burden: why not ask the obvious? J Clin Oncol (2002) 1.93
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). Ann Oncol (2009) 1.92
Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia (2000) 1.91
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet (2000) 1.90
Divalent cations differentially support transmitter release at the squid giant synapse. J Physiol (1984) 1.88
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.87
Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr (1997) 1.86
A purified plasma membrane fraction isolated from rat liver under isotonic conditions. Biochim Biophys Acta (1967) 1.86
Membranes and bile formation. Composition of several mammalian biles and their membrane-damaging properties. Biochem J (1979) 1.86
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol (2007) 1.85
Antigen binding forces of individually addressed single-chain Fv antibody molecules. Proc Natl Acad Sci U S A (1998) 1.85
Potassium activation associated with intraneuronal free calcium. Science (1978) 1.84
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2011) 1.84
Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol (2012) 1.83
Inferred slow inward current in snail neurones. Nature (1974) 1.83
Voltage-dependent facilitation of Ca2+ entry in voltage-clamped, aequorin-injected molluscan neurons. Proc Natl Acad Sci U S A (1977) 1.80
Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ (1996) 1.79
Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group. Br J Cancer (1994) 1.79